⌘K

Login Start Free

Home/Filings/4/0001213900-21-005796

4//SEC Filing

Johns Stefanie 4

Accession 0001213900-21-005796

CIK 0001711786other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:50 PM ET

Size

5.3 KB

Accession

0001213900-21-005796

Insider Transaction Report

Form 4

Period: 2021-01-29

Hoth Therapeutics, Inc.HOTH

Chief Scientific Officer

Transactions

Award
Options
2021-01-29+125,000→ 125,000 total
Exercise: $2.11From: 2021-01-29Exp: 2031-01-29→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Hoth Therapeutics, Inc.

CIK 0001711786

Entity typeother

Related Parties

1

filerCIK 0001823147

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 4:50 PM ET
Size: 5.3 KB

View on SEC.gov